HomeGUTS • NASDAQ
add
Fractyl Health Inc
Nakaraang pagsara
$1.91
Sakop ng araw
$1.80 - $2.02
Sakop ng taon
$0.83 - $3.03
Market cap
292.94M USD
Average na Volume
3.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
NDAQ
3.54%
0.00%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 22.69M | -4.65% |
Net na kita | -45.60M | -96.79% |
Net profit margin | — | — |
Kita sa bawat share | -0.71 | -65.66% |
EBITDA | -22.40M | 5.01% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 77.66M | -8.28% |
Kabuuang asset | 114.27M | -9.97% |
Kabuuang sagutin | 117.45M | 53.32% |
Kabuuang equity | -3.18M | — |
Natitirang share | 137.04M | — |
Presyo para makapag-book | -95.50 | — |
Return on assets | -64.37% | — |
Return on capital | -110.69% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -45.60M | -96.79% |
Cash mula sa mga operasyon | -22.71M | -25.92% |
Cash mula sa pag-invest | -8.00K | 96.24% |
Cash mula sa financing | 78.09M | 48,102.47% |
Net change in cash | 55.37M | 406.06% |
Malayang cash flow | -13.10M | -33.30% |
Tungkol
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1. Wikipedia
Itinatag
2010
Headquarters
Website
Mga Empleyado
101